Science No Salve For J&J In Talc Cases, $417M Verdict Shows
Johnson & Johnson's $417 million loss in the first California jury trial over the alleged link between its talcum products and ovarian cancer, following a string of defeats in Missouri, highlights...To view the full article, register now.
Already a subscriber? Click here to view full article